NMN and Cellular Senescence: NAD+ and the Hallmarks of Aging

Expert Summary

NMN (nicotinamide mononucleotide) replenishes NAD+, enabling SIRT6-mediated DNA repair (preventing the DNA damage that triggers senescence), SIRT1-mediated SASP gene suppression (reducing SASP output from existing senescent cells), and SIRT3-mediated mitochondrial quality control (preventing mitochondrial dysfunction that induces senescence). NMN addresses upstream causes of senescence without directly eliminating senescent cells.

Key Facts

• SIRT6 and DNA repair: SIRT6 is a NAD+-dependent deacetylase that recruits DNA repair enzymes to double-strand breaks. With adequate NAD+, SIRT6 maintains genomic stability; NAD+ depletion impairs SIRT6 activity, allowing DNA damage to accumulate and trigger senescence.
• SIRT1 and SASP suppression: SIRT1 deacetylates NF-κB at K310, reducing its transcriptional activity. Adequate NAD+ → active SIRT1 → reduced NF-κB activity → reduced SASP production from existing senescent cells.
• PARP maintenance: PARP-1 uses NAD+ for DNA break repair. NAD+ depletion impairs PARP-1 function → unrepaired DNA → senescence induction. NMN maintains NAD+ for continuous PARP-1 activity.
• NMN human trials: Yoshino et al. (2021, Science): NMN 250 mg/day for 10 weeks in postmenopausal women with prediabetes improved muscle insulin sensitivity and gene expression consistent with reduced cellular aging stress.
• NAD+ decline with aging: Blood NAD+ drops ~50% between age 20 and 60. This decline correlates with: reduced DNA repair capacity, increased SASP output per senescent cell, reduced mitochondrial quality control — all driving accelerated senescent cell accumulation.
• NMN + senolytics hierarchy: NMN addresses the upstream causes (DNA damage → senescence induction); senolytics address the downstream consequence (eliminate accumulated senescent cells). Both are needed; neither replaces the other.

Recommended Products

Frequently Asked Questions

Does NMN reduce senescent cell numbers?

Indirectly. By maintaining DNA repair capacity (via SIRT6/PARP) and reducing senescence induction rate, NMN lowers the rate of new senescent cell formation. It does not directly kill existing senescent cells.

Is NR as effective as NMN for these anti-senescence benefits?

NR (nicotinamide riboside) raises NAD+ via the same salvage pathway as NMN. At equivalent NAD+-raising doses, the downstream SIRT6/SIRT1/PARP benefits should be similar. NR and NMN differ in transport mechanisms but comparable NAD+ elevations are achievable with both.

Scientific References

• Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in premenopausal women. Science. 2021. PMID: 33888596
• Camacho-Pereira J et al. CD38 dictates age-related NAD decline. Cell Metabolism. 2016. PMID: 27304511